The Future in Radiation Oncology - Rock Mackie

The Saskatchewan Cancer Agency and The College of Arts & Science invites faculty, staff and students to a presentation by Thomas "Rock" Mackie, College of Arts & Science Alumni of Influence inductee for 2013. 

Mackie's presentation, "The Future in Radiation Oncology," will take place: 

Time: Friday, March 15, 12 pm

Location: Room #B111, College of Medicine

Light lunch will be provided!
RSVP your attendance to:
Emily Bocking at emily.bocking@usask.ca
on or before March 13th at noon.

Presenter Bio
Like most academics, Thomas "Rock" Mackie spends much of his time researching, teaching and applying for grants. Unlike many of his colleagues, he is also an award-winning entrepreneur whose companies have revolutionized the field of medical physics.

After earning his BSc at the U of S and PhD at the University of Alberta (''84), Mackie worked for three years at the Saskatchewan Cancer Foundation before moving to the University of Wisconsin-Madison in 1987. He has been there ever since-currently as a professor emeritus-and over the years has become one of the North America''s most respected medical physicists. While staking claim to a distinguished academic reputation, Mackie has also become a highly-accomplished entrepreneur. He was a co-founder and chairman of the board of TomoTherapy Inc., aradiation therapy treatment platform, now owned by Accuray.

He is on the Board of Novelos Therapeutics, a developer of radiopharmaceuticals; Shine MedicalTechnologies, a medical radioisotope production company; and BioIonix, a water purification company based on electro-catalytic processes. He also co-founded Geometrics Corporation in '92, which developed the PinnacleTM treatment planning system now marketed by Philips Medical.

In total, Mackie holds more than 30 patents, has published more than 180 peer-reviewed publications and has supervised more than 25 PhD students. He has received several awards, including the Sylvia Fedoruk Award from the Canadian Association of Physicists and a range of entrepreneurial achievement and research awards in the United States.